Patients who got Provenge were 20% less likely to die than those on placebo, according to a planned look by an independent monitoring committee for the study.
Uppal had also planned to demonstrate a piece of spyware capable of monitoring information from programs that use the FIX protocol, or financial information exchange, to make high-speed trades.